Joint Corp (JYNT)
NASDAQ:JYNT
JYNT Stock Chart & Stats
$8.48
$0.12(1.11%)
At close: 4:00 PM EST
$8.48
$0.12(1.11%)
Day’s Range― - ―
52-Week Range$7.50 - $13.47
Previous CloseN/A
Volume11.07K
Average Volume (3M)133.85K
Market Cap
$119.69M
Enterprise Value$102.54M
Total Cash (Recent Filing)$23.60M
Total Debt (Recent Filing)$2.01M
Price to Earnings (P/E)45.4
Beta1.07
Next Earnings
Apr 30, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding14,114,334
10 Day Avg. Volume93,155
30 Day Avg. Volume133,848
Financial Highlights & Ratios
PEG Ratio-0.34
Price to Book (P/B)8.77
Price to Sales (P/S)2.40
P/FCF Ratio394.27
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue1.87
Enterprise Value/Gross Profit2.44
Enterprise Value/Ebitda90.74
Forecast
1Y Price Target
$9.64Price Target Upside13.68% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)0.27
Revenue Forecast (FY)$60.40M
Bulls Say, Bears Say
Bulls Say
Cost ManagementJYNT's gross margin was above consensus and estimates, indicating effective cost management.
Franchise TransitionJYNT reached an agreement to sell 45 corporate clinics, advancing its transition to a full franchise model.
Net IncomeJYNT's net income from continuing operations was well above estimates due to significantly lower-than-expected operating expenses.
Bears Say
Revenue GrowthJYNT's reduced sales outlook and weakening revenue growth reflect mounting headwinds in patient acquisition and a deliberate slowdown in clinic expansion.
Sales PerformanceSystem-wide comparable sales declined by 2.0%, below prior guidance, indicating potential challenges in sales performance.
Unit GrowthThe pace of refranchising appears to be slowing new openings, limiting near-term unit growth.
Joint News
JYNT FAQ
What was Joint Corp’s price range in the past 12 months?
Joint Corp lowest stock price was $7.50 and its highest was $13.47 in the past 12 months.
What is Joint Corp’s market cap?
Joint Corp’s market cap is $119.69M.
When is Joint Corp’s upcoming earnings report date?
Joint Corp’s upcoming earnings report date is Apr 30, 2026 which is in 33 days.
How were Joint Corp’s earnings last quarter?
Joint Corp released its earnings results on Mar 12, 2026. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02.
Is Joint Corp overvalued?
According to Wall Street analysts Joint Corp’s price is currently Undervalued.
Does Joint Corp pay dividends?
Joint Corp does not currently pay dividends.
What is Joint Corp’s EPS estimate?
Joint Corp’s EPS estimate is 0.03.
How many shares outstanding does Joint Corp have?
Joint Corp has 14,114,334 shares outstanding.
What happened to Joint Corp’s price movement after its last earnings report?
Joint Corp reported an EPS of $0.06 in its last earnings report, beating expectations of $0.04. Following the earnings report the stock price went up 2.314%.
Which hedge fund is a major shareholder of Joint Corp?
Currently, no hedge funds are holding shares in JYNT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Joint Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$9.64 (13.68% Upside)
$9.64 (13.68% Upside)
Insider Transactions
Bought Shares
Worth $368.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.36%
12-Months-Change
Fundamentals
Return on Equity
-3.70%
Trailing 12-Months
Asset Growth
-12.83%
Trailing 12-Months
Company Description
Joint Corp
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
JYNT Company Deck
JYNT Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicates clear strategic progress (notably substantial refranchising toward a capital-light franchisor model, improved consolidated adjusted EBITDA, strong patient experience metrics, and definitive run-rate margin targets) while acknowledging meaningful near-term operational challenges (chiefly weak new-patient acquisition and Q4 comp declines). Management provided concrete actions—national marketing, SEO, pricing tests, conversion/retention programs, cost rightsizing—and a quantified view of expected post-refranchising profitability. Given the combination of current headwinds in new-patient flow but material improvements in profitability, balance-sheet actions, and a credible plan to complete refranchising (with projected step-up in margins), the positives modestly outweigh the negatives.View all JYNT earnings summariesJYNT Stock 12 Month Forecast
Average Price Target
$9.64
▲(13.68% Upside)
Technical Analysis
Ownership Overview
13.22% Insiders
13.15% Mutual Funds
42.36% Other Institutional Investors
22.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---